CAR-T toxicity management shifts toward phenotype- and mechanism-based intervention
CAR-T toxicity management is shifting toward phenotype- and mechanism-based intervention. Key issues include CRS, ICANS, IEC-HS, and long-term risks of cytopenia and infection.